{
    "organizations": [],
    "uuid": "21130f17bebb6dd04e9c32ebf614f51787eb67f2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-horizon-pharma-plc-announces-q4-no/brief-horizon-pharma-plc-announces-q4-non-gaap-earnings-per-share-0-29-idUSASB0C7YQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Horizon Pharma PLC Announces Q4 Non-Gaap Earnings Per Share $0.29",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Horizon Pharma Plc:\n* ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS\n* Q4 NON-GAAP EARNINGS PER SHARE $0.29\n* SEES FY 2018 SALES $1.15 BILLION TO $1.18 BILLION * Q4 SALES $274.2 MILLION * Q4 GAAP LOSS PER SHARE $0.28 * ‍FULL-YEAR 2018 ADJUSTED EBITDA GUIDANCE OF $370 MILLION TO $395 MILLION​\n* Q4 EARNINGS PER SHARE VIEW $0.22, REVENUE VIEW $264.5 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 REVENUE VIEW $1.14 BILLION -- THOMSON REUTERS I/B/E/S\n* HORIZON PHARMA SAYS Q4 NET SALES DRIVEN BY CONTINUED STRONG GROWTH FROM CO‘S ORPHAN & RHEUMATOLOGY BUSINESS UNITS​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-02-28T20:10:00.000+02:00",
    "crawled": "2018-03-01T21:00:16.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "horizon",
        "pharma",
        "plc",
        "announces",
        "result",
        "q4",
        "earnings",
        "per",
        "share",
        "see",
        "fy",
        "sale",
        "billion",
        "billion",
        "q4",
        "sale",
        "million",
        "q4",
        "gaap",
        "loss",
        "per",
        "share",
        "adjusted",
        "ebitda",
        "guidance",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "fy2018",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "horizon",
        "pharma",
        "say",
        "q4",
        "net",
        "sale",
        "driven",
        "continued",
        "strong",
        "growth",
        "co",
        "orphan",
        "rheumatology",
        "business",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}